Survey of Medical Liaison Practices No. 2: Assessing Training Techniques and Demonstrating Value of Medical Liaisons

  • PDF / 12,323,657 Bytes
  • 14 Pages / 612 x 792 pts (letter) Page_size
  • 98 Downloads / 168 Views

DOWNLOAD

REPORT


67

Survey of Medical Liaison Practices No. 2: Assessing Training Techniques and Demonstrating Value of Medical Liaisons

Christopher M. Morronr, PhariD Medical Liaison Consultant. Eli Lilly and Company

1. Lynn Bass, PharmD Senior Regional Medical Liaison. Amgen lnc. Croig Klingrr, RPh Senior Medical Liaison Consultant. Eli Lily and Company

Key Words Medical liaison; Pharmaceutical industry; Field based; Employment; Survey: Benchmarking Corrrspordrncr Address Christopher M. Marrone. PharmD. Lilly Corporate Center. Indianapolis, Indiana 46285 (e-mail: [email protected]).

Data previously presented at the 42ndAnnual Drug Information Association Annual Meeting. Philadelphia, PA, June 19.2006.

In an effort to assess medical liaison trends across the pharmaceutical indusw, a survey of medical liaison managers was previously administered and published. 'Ihe intent of the initial survey was to identifi o v d l approaches used by pharmaceutical companies in defining and managing the medical liaison rde. We conducted thisfdlwup survey to focus on areas identified by the initial survey participants as major challenges. The current surveyfocused on developing and conducfing medical liaison training, as well as demonstmting and communicating

I N T R O D U CTI 0 N Medical liaisons develop and enhance relationships with key opinion leaders (KOLs) within the health care community to contribute to improved outcomes for patients. Activities of medical liaisons include dissemination of medical information upon request, exploration of mutual clinical and scientific interests with health care providers, facilitation of professional education, and understanding the dynamics and unmet needs within therapeutic areas. Current, in-depth benchmarking data on medical liaison groups across the pharmaceutical industry do not exist in the published literature. To fill this gap, a previous survey was conducted with the intent of identifying the overall approaches used by pharmaceutical companies in defining and managing the medical liaison role (l).The survey demonstrated that there are similarities in medical liaison positions across the industry, such as reporting structure, job responsibilities, and medical liaison credentials. Despite these similarities, there are many areas in which medical liaison roles differ between companies, such as the use of metrics and training of medical liaisons. On the basis of the re-

the value of medical liaison programs. The survey was sent to appraxirnately 1,275recipients with instructions requesting that the survey was to be completed only by managers or directors of medical liaison programs. The survey results indicated the fdlowing: There is a broad range of new hire and experienced medical liaison training practices, training of newly hired medical liaison difers fiom that of expetienced medical liaisons, and many innovative practices are used to overcome the challenge of demonstrating the value of a medical liaison.

sponses received, it appeared that medical liaison organizations throughout the i